Nastorazepide Calcium

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameNastorazepide Calcium
Drug Alias Name那托西派nastorazepidanastorazepidum那托西匹Z-360
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin B receptor antagonists
TargetsCholecystokinin B receptor
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwanUnited KingdomSouth Korea +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZeria
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZeria Pharmaceutical
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A